Exact Mass: 432.01828280000007
Exact Mass Matches: 432.01828280000007
Found 74 metabolites which its exact mass value is equals to given mass value 432.01828280000007,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Se-Adenosylselenohomocysteine
Se-Adenosylselenohomocysteine is an intermediate in Selenoamino acid metabolism. Se-Adenosylselenohomocysteine is the second to last step in the synthesis of Selenohomocystine and is converted from Se-Adenosylselenomethionine via the enzyme Transferases (EC 2.1.1.-). It is then. converted to Selenohomocysteine via the enzyme adenosylhomocysteinase (EC 3.3.1.1). Se-Adenosylselenohomocysteine is an intermediate in Selenoamino acid metabolism. Se-Adenosylselenohomocysteine is the second to last step in the synthesis of Selenohomocystine and is converted from Se-Adenosylselenomethionine via the enzyme Transferases (EC 2.1.1.-). It is then
Mollicellin F
Mollicellin F is classified as a Food Contaminant (code WG) in the DFC.
lamotrigine-2-N-glucuronide
lamotrigine-2-N-glucuronide is a metabolite of lamotrigine. Lamotrigine, marketed in the US and most of Europe as Lamictal by GlaxoSmithKline, is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder. It is also used as an adjunct in treating depression, though this is considered off-label usage. For epilepsy, it is used to treat focal seizures, primary and secondary tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. (Wikipedia)
Se-Adenosyl-L-selenohomocysteine
Se-Adenosyl-L-selenohomocysteine is classified as a member of the 5-deoxyribonucleosides. 5-deoxyribonucleosides are nucleosides in which the oxygen atom at the 5position of the ribose moiety has been replaced by another atom. The nucleobases here are limited to purine, pyrimidine, and pyridine derivatives. Se-Adenosyl-L-selenohomocysteine is considered to be slightly soluble (in water) and acidic
5-Chloro-4-N-(cyclopropylmethyl)-2-methyl-4-N-propyl-6-N-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine
C18H20Cl4N4 (432.04420000000005)
CAY10608
C18H22Cl2N2O4S (432.06772720000004)
1-(2,4-Dichlorophenyl)-2-(1-imidazolyl)ethanol glucuronide
mollicellin F
A member of the class of depsidones that is 3,4-dihydro-H,11H-chromeno[6,7-b][1,4]benzodioxepine substituted by a chloro group at position 9, hydroxy groups at positions 8 and 13, methyl groups at positions 2, 2, 5 and 10, oxo groups at positions 4 and 11 and a formyl group at position 7. Isolated from Chaetomium brasiliense, it exhibits cytotoxic activity.
2-(Perfluorohexyl)ethyl methacrylate
C12H9F13O2 (432.03949299999994)
Methyl 8-iodo-4,5,6,7-tetramethoxy-2-naphthoate
C16H17IO6 (432.00698520000003)
1,3-Bis(2,4-diaminophenoxy)propane tetrahydrochloride
N-[[5-(1H-pyrazol-5-yl)-1,3,4-thiadiazol-2-yl]methyl]-4-(2,4,6-trifluorobenzoyl)-1H-pyrrole-2-carboxamide
Clometocillin
C17H18Cl2N2O5S (432.03134380000006)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CE - Beta-lactamase sensitive penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Benzyltriphenylphosphonium bromide
C25H22BrP (432.06424020000003)
DIMETHYL 2-(3-BROMO-5-FORMYL-4-((2-METHOXYETHOXY)METHOXY)PHENYL)SUCCINATE
3-IODO-N-(2-MORPHOLIN-4-YL-ETHYL)-BENZENESULFONAMIDE HYDROCHLORIDE
C12H18ClIN2O3S (431.97713780000004)
Padsevonil
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
Pamoic acid disodium
Pamoic acid disodium is a potent GPR35 agonist with an EC50 value of 79 nM. Pamoic acid disodium induces GPR35 internalization and activates ERK1/2 with EC50 values of 22 nM and 65 nM, respectively. Pamoic acid disodium potently recruits β-arrestin2 to GPR35 and has an antinociceptive effect[1].
Chloro(methyldiphenylphosphine)gold(I),95
C13H13AuClP (432.01089580000007)
3-Acetoxymercuri-4-aminobenzenesulfonamide
C8H10HgN2O4S (432.00675800000005)
D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
2-[5-[(3,4-Dichlorophenyl)methylthio]-4-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]pyridine
2-{[(5-{4-Chloro-3-nitrophenyl}-2-furyl)methylene]amino}-3-(2-furyl)imidazo[1,2-a]pyridine
C22H13ClN4O4 (432.06252880000005)
N-(5-chloro-2-oxo-3-indolyl)-2-thiophen-2-yl-4-quinolinecarbohydrazide
C22H13ClN4O2S (432.04477080000004)
5-(4-Dibenzothiophenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine
1-[[4-(6-Chloro-3-pyridinyl)phenyl]methyl]-5-(trifluoromethoxy)indole-2,3-dione
C21H12ClF3N2O3 (432.0488508000001)
2-[(4,6-dioxo-5-phenyl-1,4,5,6-tetrahydropyrimidin-2-yl)sulfanyl]-N-(4-sulfamoylphenyl)acetamide
Ethyl 2-[(4-fluorobenzoyl)carbamothioylamino]-4-(5-methylfuran-2-yl)thiophene-3-carboxylate
8-{(2E)-2-[(2Z)-2-bromo-3-phenylprop-2-en-1-ylidene]hydrazinyl}-6-hydroxy-7-(2-hydroxyethyl)-3-methyl-3,7-dihydro-2H-purin-2-one
(2S,3S,4S,5R)-6-[3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazin-2-ium-2-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid
5-Chloro-4-N-(cyclopropylmethyl)-2-methyl-4-N-propyl-6-N-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine
C18H20Cl4N4 (432.04420000000005)
L-adenosylselenohomocysteine
A selenoamino acid that is L-selenomethionine in which the methyl group attached to the selenium is replaced by a 5-adenosyl group.
2,6-Dichloro-2',3',5'-triacetyl-purine riboside
2,6-Dichloro-2',3',5'-triacetyl-purine riboside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
P2Y2R/GPR17 antagonist 1
C19H13ClN2O6S (432.01828280000007)
P2Y2R/GPR17 antagonist 1 (Compound 14m) is a dual P2Y2R and GPR17 antagonist with IC50 values of 3.17 μM and 1.67 μM against P2Y2R and GPR17, respectively. P2Y2R/GPR17 antagonist 1 shows excellent metabolic stability in human liver microsomes[1].
6-chloro-5,12-dihydroxy-7,15,15,19-tetramethyl-9,17-dioxo-2,10,14-trioxatetracyclo[9.8.0.0³,⁸.0¹³,¹⁸]nonadeca-1(19),3,5,7,11,13(18)-hexaene-4-carbaldehyde
(5s,8r,9r)-9-(2,4-dibromo-5-methoxyphenyl)-8-hydroxy-7-methyl-1,7-diazaspiro[4.4]nonan-6-one
2-{[(5z)-5-{3-[(4-bromo-1h-pyrrol-2-yl)formamido]propylidene}-2-iminoimidazolidin-4-ylidene]amino}ethanesulfonic acid
C13H17BrN6O4S (432.02153020000003)
(1r,7s,8s,11r)-11-(hydroxymethyl)-17-methyl-10,16-dioxo-12,13,14,15-tetrathia-9,17-diazatetracyclo[9.4.2.0¹,⁹.0³,⁸]heptadeca-3,5-dien-7-yl acetate
(1r,1'r,9's,12'r,13'r)-13'-hydroxy-18'-methyl-2',15'-dioxa-10',11'-dithia-16',18'-diazaspiro[cyclohexane-1,14'-pentacyclo[10.5.2.0¹,⁹.0³,⁸.0¹²,¹⁶]nonadecane]-3,3',5',7'-tetraene-2,17',19'-trione
5-{2-[2-(2-{[2,2'-bithiophen]-5-yl}ethynyl)cyclobutyl]ethynyl}-2,2'-bithiophene
4-chloro-7-(3,5-dichloro-2,4-dimethoxy-6-methylphenoxy)-5-methoxy-3h-2-benzofuran-1-one
2-[(5-{3-[(4-bromo-1h-pyrrol-2-yl)formamido]propylidene}-2-iminoimidazolidin-4-ylidene)amino]ethanesulfonic acid
C13H17BrN6O4S (432.02153020000003)